Pasar al contenido principal

REGULACION EPIGENETICA DE LA RESPUESTA TRANSCRIPCIONAL DEPENDIENTE DE ACTIVIDAD: IMPLICACIONES EN APRENDIZAJE, MEMORIA AND RETRASO MENTAL

SAF2011-22855

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry

  • Ateca Cabarga, Juan Carlos
  • Cosa, Alejandro
  • Pallares, Vicente
  • Lopez-Atalaya, Jose P.
  • Barco, Angel
  • Canals, Santiago
  • Moratal, David|||0000-0002-2825-3646
The Rubinstein-Taybi Syndrome (RSTS) is a congenital disease that affects brain development causing severe cognitive deficits. In most cases the disease is associated with dominant mutations in the gene encoding the CREB binding protein (CBP). In this work, we present the first quantitative analysis of brain abnormalities in a mouse model of RSTS using magnetic resonance imaging (MRI) and two novel self-developed automated algorithms for image volumetric analysis. Our results quantitatively confirm key syndromic features observed in RSTS patients, such as reductions in brain size (-16.31%, p < 0.05), white matter volume (-16.00%, p < 0.05), and corpus callosum (-12.40%, p < 0.05). Furthermore, they provide new insight into the developmental origin of the disease. By comparing brain tissues in a region by region basis between cbp(+/-) and cbp(+/+) littermates, we found that cbp haploinsufficiency is specifically associated with significant reductions in prosencephalic tissue, such us in the olfactory bulb and neocortex, whereas regions evolved from the embryonic rhombencephalon were spared. Despite the large volume reductions, the proportion between gray-, white-matter and cerebrospinal fluid were conserved, suggesting a role of CBP in brain size regulation. The commonalities with holoprosencephaly and arhinencephaly conditions suggest the inclusion of RSTS in the family of neuronal migration disorders., We are grateful to Begona Fernandez for her excellent technical assistance. We would like to thank S. Sawiak (Wolfson Imaging Centre, University of Cambridge, Cambridge, United Kingdom) for the mouse brain tissue probability maps and the SPMmouse plug-in, and to N. Kovacevic (Mouse Imaging Centre, Hospital for Sick Children, Toronto, Ontario, Canada) for the atlas of the mouse brain. Supported by grants from the Spanish MINECO to S.C. (BFU 2012-39958) and MINECO and FEDER to D.M. (TEC 2012-33778) and from MINECO (SAF2011-22855) and Generalitat Valenciana (Prometeo/2012/005) to A.B. The Instituto de Neurociencias is "Centre of Excellence Severo Ochoa".
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

cAMP-responsive element-binding protein (CREB) and cAMP co-regulate activator protein 1 (AP1)-dependent regeneration-associated gene expression and neurite growth

  • Ma, Thong C.
  • Barco, Ángel
  • Ratan, Rajiv R.
  • Willis, Dianna E.
To regenerate damaged axons, neurons must express a cassette of regeneration-associated genes (RAGs) that increases intrinsic growth capacity and confers resistance to extrinsic inhibitory cues. Here we show that dibutyrl-cAMP or forskolin combined with constitutive-active CREB are superior to either agent alone in driving neurite growth on permissive and inhibitory substrates. Of the RAGs examined, only arginase 1 (Arg1) expression correlated with the increased neurite growth induced by the cAMP/CREB combination, both of which were AP1-dependent. This suggests that cAMP-induced AP1 activity is necessary and interacts with CREB to drive expression of RAGs relevant for regeneration and demonstrates that combining a small molecule (cAMP) with an activated transcription factor (CREB) stimulates the gene expression necessary to enhance axonal regeneration., This work was supported, in whole or in part, by National Institutes of Health Grant NR010797 (to D. W.). This work was also supported by grants from the Dr. Miriam and Sheldon G. Adelson Foundation (to R. R.), The Center for Research Excellence in Spinal Cord Injury (Grant DOHC019772; to R. R.), and the Burke Medical Research Institute Foundation (to D. W.). The Barco laboratory is supported by Grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Can changes in histone acetylation contribute to memory formation?

  • López-Atalaya, José P.
  • Barco, Ángel
Neuronal histone acetylation has been postulated to be a mnemonic substrate and a target for memory enhancers and neuropsychiatric drugs. Here we critically evaluate this view and examine the apparent conflict between the proposed instructive role for histone acetylation in memory-related transcription and the insights derived from genomic and genetic studies in other systems. We next discuss the suitability of activity-dependent neuronal histone acetylation as a mnemonic substrate and debate alternative interpretations of current evidence. We believe that further progress in our understanding of the role of histone acetylation and other epigenetic modifications in neuronal plasticity, memory, and neuropsychiatric disorders requires a clear discrimination between cause and effect so that novel epigenetics-related processes can be distinguished from classical transcriptional mechanisms., Research in the Barco laboratory is supported by grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana. The Instituto de Neurociencias is a Centre of Excellence Severo Ochoa., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry

  • Ateca-Cabarga, Juan C.
  • Cosa-Linan, Alejandro
  • Pallarés, Vicente
  • López-Atalaya, José P.
  • Barco, Ángel
  • Canals, Santiago
  • Moraltal Pérez, David
The Rubinstein-Taybi Syndrome (RSTS) is a congenital disease that affects brain development causing severe cognitive deficits. In most cases the disease is associated with dominant mutations in the gene encoding the CREB binding protein (CBP). In this work, we present the first quantitative analysis of brain abnormalities in a mouse model of RSTS using magnetic resonance imaging (MRI) and two novel self-developed automated algorithms for image volumetric analysis. Our results quantitatively confirm key syndromic features observed in RSTS patients, such as reductions in brain size (−16.31%, p < 0.05), white matter volume (−16.00%, p < 0.05) and corpus callosum (−12.40%, p < 0.05). Furthermore, they provide new insight into the developmental origin of the disease. By comparing brain tissues in a region by region basis between cbp+/− and cbp+/+ littermates, we found that cbp haploinsufficiency is specifically associated with significant reductions in prosencephalic tissue, such us in the olfactory bulb and neocortex, whereas regions evolved from the embryonic rhombencephalon were spared. Despite the large volume reductions, the proportion between gray-, white-matter and cerebrospinal fluid were conserved, suggesting a role of CBP in brain size regulation. The commonalities with holoprosencephaly and arhinencephaly conditions suggest the inclusion of RSTS in the family of neuronal migration disorders., Supported by grants from the Spanish MINECO to S.C. (BFU 2012–39958) and MINECO and FEDER to D.M. (TEC 2012–33778) and from MINECO (SAF2011-22855) and Generalitat Valenciana (Prometeo/2012/005) to A.B. The Instituto de Neurociencias is “Centre of Excellence Severo Ochoa”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Blocking miRNA biogenesis in adult forebrain neurons enhances seizure susceptibility, fear memory, and food intake by increasing neuronal responsiveness

  • Fiorenza, Anna
  • López-Atalaya, José P.
  • Rovira, Victor
  • Scandaglia, Marilyn
  • Geijo-Barrientos, Emilio
  • Barco, Ángel
The RNase Dicer is essential for the maturation of most microRNAs, a molecular system that plays an essential role in fine-tuning gene expression. To gain molecular insight into the role of Dicer and the microRNA system in brain function, we conducted 2 complementary RNA-seq screens in the hippocampus of inducible forebrain-restricted Dicer1 mutants aimed at identifying the microRNAs primarily affected by Dicer loss and their targets, respectively. Functional genomics analyses predicted the main biological processes and phenotypes associated with impaired microRNA maturation, including categories related to microRNA biology, signal transduction, seizures, and synaptic transmission and plasticity. Consistent with these predictions, we found that, soon after recombination, Dicer-deficient mice exhibited an exaggerated seizure response, enhanced induction of immediate early genes in response to different stimuli, stronger and more stable fear memory, hyperphagia, and increased excitability of CA1 pyramidal neurons. In the long term, we also observed slow and progressive excitotoxic neurodegeneration. Overall, our results indicate that interfering with microRNA biogenesis causes an increase in neuronal responsiveness and disrupts homeostatic mechanisms that protect the neuron against overactivation, which may explain both the initial and late phenotypes associated with the loss of Dicer in excitatory neurons., A.F. held a doctoral fellowship funded by the Consolider programme (grant number CSD2007-00023). Research at A.B.'s laboratory is supported by a grant from the Spanish MINECO (SAF2011-22855), Prometeo/2012/005 from the Generalitat Valenciana and a NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation. Research at E.G.B.'s laboratory is supported by a MINECO grant (BFU2011-27326). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin

  • López-Atalaya, José P.
  • Valor, Luis Miguel
  • Barco, Ángel
The number of genetic syndromes associated with intellectual disability that are caused by mutations in genes encoding chromatin-modifying enzymes has sharply risen in the last decade. We discuss here a neurodevelopmental disorder, the Rubinstein–Taybi syndrome (RSTS), originated by mutations in the genes encoding the lysine acetyltransferases CBP and p300. We first describe clinical and genetic aspects of the syndrome to later focus on the insight provided by the research in animal models of this disease. These studies have not only clarified the molecular etiology of RSTS and helped to dissect the developmental and adult components of the syndrome but also contributed to outline some important connections between epigenetics and cognition. We finally discuss how this body of research has opened new venues for the therapeutic intervention of this currently untreatable disease and present some of the outstanding questions in the field. We believe that the progress in the understanding of this rare disorder also has important implications for other intellectual disability disorders that share an epigenetic origin., Authors' research is supported by Grants SAF2011-22855 and SAF2011-22506 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fine-tuned SRF activity controls asymmetrical neuronal outgrowth: implications for cortical migration, neural tissue lamination and circuit assembly

  • Scandaglia, Marilyn
  • Benito, Eva
  • Morenilla-Palao, Cruz
  • Fiorenza, Anna
  • Blanco, Beatriz del
  • Coca, Yaiza
  • Herrera, Eloisa
  • Barco, Ángel
The stimulus-regulated transcription factor Serum Response Factor (SRF) plays an important role in diverse neurodevelopmental processes related to structural plasticity and motile functions, although its precise mechanism of action has not yet been established. To further define the role of SRF in neural development and distinguish between cell-autonomous and non cell-autonomous effects, we bidirectionally manipulated SRF activity through gene transduction assays that allow the visualization of individual neurons and their comparison with neighboring control cells. In vitro assays showed that SRF promotes survival and filopodia formation and is required for normal asymmetric neurite outgrowth, indicating that its activation favors dendrite enlargement versus branching. In turn, in vivo experiments demonstrated that SRF-dependent regulation of neuronal morphology has important consequences in the developing cortex and retina, affecting neuronal migration, dendritic and axonal arborization and cell positioning in these laminated tissues. Overall, our results show that the controlled and timely activation of SRF is essential for the coordinated growth of neuronal processes, suggesting that this event regulates the switch between neuronal growth and branching during developmental processes., MS held a doctoral fellowship funded by MINECO. We also thank Eric R. Kandel for his support in the generation of caSRF mice. Research at AB’s lab is supported by grants SAF2011-22855 and SAF2014-56197-R from MINECO, Prometeo/2012/005 from the Generalitat Valenciana and a NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation. Research at EH’s lab is supported by the MINECO grant BFU-2013-47832 and the ERC grant 2011-StG-20101109. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease

  • Valor, Luis Miguel
  • Guiretti, Deisy
  • López-Atalaya, José P.
  • Barco, Ángel
Transcriptional dysregulation is an important early feature of polyglutamine diseases. One of its proposed causes is defective neuronal histone acetylation, but important aspects of this hypothesis, such as the precise genomic topography of acetylation deficits and the relationship between transcriptional and acetylation alterations at the whole-genome level, remain unknown. The new techniques for the mapping of histone post-translational modifications at genomic scale enable such global analyses and are challenging some assumptions about the role of specific histone modifications in gene expression. We examined here the genome-wide correlation of histone acetylation and gene expression defects in a mouse model of early onset Huntington's disease. Our analyses identified hundreds of loci that were hypoacetylated for H3K9,14 and H4K12 in the chromatin of these mice. Surprisingly, few genes with altered transcript levels in mutant mice showed significant changes in these acetylation marks and vice versa. Our screen, however, identified a subset of genes in which H3K9,14 deacetylation and transcriptional dysregulation concur. Genes in this group were consistently affected in different brain areas, mouse models, and tissue from patients, which suggests a role in the etiology of this pathology. Overall, the combination of histone acetylation and gene expression screenings demonstrates that histone deacetylation and transcriptional dysregulation are two early, largely independent, manifestations of polyglutamine disease and suggests that additional epigenetic marks or mechanisms are required for explaining the full range of transcriptional alterations associated with this disorder., This work was supported by the Spanish Ministry of Science and Innovation (Grants SAF2008-03194-E (part of the coordinated ERA-Net NEURON project Epitherapy) and SAF2011-22855 to A.B., SAF2011-22506 to L.M.V., and CSD2007-00023) and grants from the Generalitat Valenciana (Prometeo/2012/005), Fundació La Marató de TV3 (063510) and Fundació Gent per Gent. We thank the support of Asociación Valenciana de Enfermedad de Huntington (AVAEH). L.M.V.'s research is supported by a Ramón y Cajal contract from the Spanish Ministry of Economy and Competiveness. D.G. and J.P.L.-A. hold, respectively, a predoctoral fellowship (JAE-pre) and a postdoctoral contract (JAE-doc) from the Program “Junta para la Ampliación de Estudios” cofunded by the Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition

  • López-Atalaya, José P.
  • Ito, Satomi
  • Valor, Luis Miguel
  • Benito, Eva
  • Barco, Ángel
Histone deacetylase inhibitors (HDACis) have been shown to potentiate hippocampal-dependent memory and synaptic plasticity and to ameliorate cognitive deficits and degeneration in animal models for different neuropsychiatric conditions. However, the impact of these drugs on hippocampal histone acetylation and gene expression profiles at the genomic level, and the molecular mechanisms that underlie their specificity and beneficial effects in neural tissue, remains obscure. Here, we mapped four relevant histone marks (H3K4me3, AcH3K9,14, AcH4K12 and pan-AcH2B) in hippocampal chromatin and investigated at the whole-genome level the impact of HDAC inhibition on acetylation profiles and basal and activity-driven gene expression. HDAC inhibition caused a dramatic histone hyperacetylation that was largely restricted to active loci pre-marked with H3K4me3 and AcH3K9,14. In addition, the comparison of Chromatin immunoprecipitation sequencing and gene expression profiles indicated that Trichostatin A-induced histone hyperacetylation, like histone hypoacetylation induced by histone acetyltransferase deficiency, had a modest impact on hippocampal gene expression and did not affect the transient transcriptional response to novelty exposure. However, HDAC inhibition caused the rapid induction of a homeostatic gene program related to chromatin deacetylation. These results illuminate both the relationship between hippocampal gene expression and histone acetylation and the mechanism of action of these important neuropsychiatric drugs., J.L.A. holds a postdoctoral contract (JAE-doc) from the Program ‘Junta para la Ampliación de Estudios’ co-funded by the Fondo Social Europeo (FSE). S.I. holds a Juan de la Cierva contract from the Spanish Ministry of Economy and Competitiveness. L.M.V. holds a Ramón y Cajal contract from the Spanish Ministry of Economy and Competitiveness. [CSD2007-00023, SAF2008-03194-E] (part of the coordinated ERA-Net NEURON project Epitherapy), [SAF2011-22855 and SAF2011-22506 to L.M.V.], Spanish Ministry of Economy and Competitiveness; [Prometeo/2012/005] Generalitat Valenciana; and the Fundació Gent per Gent., Funding for open access charge: Spanish Ministry of Economy and Competitiveness., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Histone H3 lysine methylation in cognition and intellectual disability disorders

  • Parkel, Sven
  • López-Atalaya, José P.
  • Barco, Ángel
Recent research indicates that epigenetic mechanisms and, in particular, the post-translational modification (PTM) of histones may contribute to memory encoding and storage. Among the dozens of possible histone PTMs, the methylation/demethylation of lysines in the N-terminal tail of histone H3 exhibits particularly strong links with cognitive abilities. First, the persistence and tight association with distinct transcriptional states of the gene make these modifications particularly suitable for being part of the molecular underpinnings of memory storage. Second, correlative evidence indicates that the methylation/demethylation of lysines in histone H3 is actively regulated during memory processes. Third, several enzymes regulating these PTMs are associated with intellectual disability disorders. We review here these three lines of evidence and discuss the potential role of epigenetic mechanisms centered on the methylation of lysine residues on histone H3 in neuroplasticity and neurodevelopmental disorders associated with intellectual disability., Research at Barco’s lab is supported by grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana. J.P.L.-A. holds a postdoctoral contract (JAE-doc) from the program “Junta para la Ampliacion de Estudios, ”co-funded by the Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders

  • Valor, Luis Miguel
  • Viosca, José
  • López-Atalaya, José P.
  • Barco, Ángel
Neuropsychiatric pathologies, including neurodegenerative diseases and neurodevelopmental syndromes, are frequently associated with dysregulation of various essential cellular mechanisms, such as transcription, mitochondrial respiration and protein degradation. In these complex scenarios, it is difficult to pinpoint the specific molecular dysfunction that initiated the pathology or that led to the fatal cascade of events that ends with the death of the neuron. Among the possible original factors, epigenetic dysregulation has attracted special attention. This review focuses on two highly related epigenetic factors that are directly involved in a number of neurological disorders, the lysine acetyltransferases CREB-binding protein (CBP) and E1A-associated protein p300 (p300). We first comment on the role of chromatin acetylation and the enzymes that control it, particularly CBP and p300, in neuronal plasticity and cognition. Next, we describe the involvement of these proteins in intellectual disability and in different neurodegenerative diseases. Finally, we discuss the potential of ameliorative strategies targeting CBP/p300 for the treatment of these disorders., Research at Barco’s lab is supported by the grants SAF2008-03194-E (part of the coordinated ERA-Net NEURON project Epitherapy), SAF2011-22855 and CSD2007-00023 from the Spanish Ministry of Science and Innovation, the GVA Grant Prometeo/2012/005 and a grant from the Fundació Gent per Gent. LMV is supported by a Ramón y Cajal contract and the grant SAF2011-22506 from the Spanish Ministry of Economy and Competiveness. JLA holds a postdoctoral contract (JAE-doc) from the Program “Junta para la Ampliación de Estudios” co-funded by the Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes

  • Guiretti, Deisy
  • Sempere, Ana
  • López-Atalaya, José P.
  • Ferrer-Montiel, Antonio
  • Barco, Ángel
  • Valor, Luis Miguel
Defective epigenetic regulation has been postulated as a possible cause for the extensive and premature transcriptional dysregulation observed in experimental models of Huntington's disease (HD). In this study, we extended our observations in the N171-82Q mouse strain relating to the limited impact of polyQ pathology on the global histone acetylation to other animal and cellular models of HD, namely the R6/1 and YAC128 strains, striatal-electroporated mice, primary neuronal cultures and stably transfected PC12 cells. In the absence of bulk chromatin changes, we nonetheless documented histone deacetylation events at the transcription start sites (TSS) of genes relevant to neuronal functions (e.g., Rin1, Plk5, Igfbp5, Eomes, and Fos). In some instances, these local deficits were associated with an increased susceptibility to transcriptional dysregulation (e.g., Camk1g and Rasl11b) and the defective trimethylation of histone H3 at lysine 4 (H3K4me3), another covalent modification of histone tails that is related to active transcription and is also altered in HD. Overall, this study provides further insight into the nature and extent of epigenetic dysregulation in HD pathology., This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants SAF2011-22506, SAF2011-22855, BFU2012-39092-C02-01 and SAF2014-56197-R), the Fundació Gent per Gent (19-NEURO), Asociación Valenciana de Enfermedad de Huntington (AVAEH) and Generalitat Valenciana (Prometeo/2012/005, ISIC/2012/009 and Prometeo/2014/011). L.M.V.'s research is further supported by a Ramón y Cajal contract from the Spanish Ministry of Economy and Competitiveness. D.G. thanks the CSIC for a predoctoral fellowship (JAE-pre from the Programme “Junta para la Ampliación de Estudios”, which is co-funded by the Fondo Social Europeo (FSE)). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The neuronal activity-driven transcriptome

  • Benito, Eva
  • Barco, Ángel
Activity-driven transcription is a key event associated with long-lasting forms of neuronal plasticity. Despite the efforts to investigate the regulatory mechanisms that control this complex process and the important advances in the knowledge of the function of many activity-induced genes in neurons, as well as the specific contribution of activity-regulated transcription factors, our understanding of how activity-driven transcription operates at the systems biology level is still very limited. This review focuses on the research of neuronal activity-driven transcription from an “omics” perspective. We will discuss the different high-throughput approaches undertaken to characterize the gene programs downstream of specific activity-regulated transcription factors, including CREB, SRF, MeCP2, Fos, Npas4, and others, and the interplay between epigenetic and transcriptional mechanisms underlying neuronal plasticity changes. Although basic questions remain unanswered and important challenges still lie ahead, the refinement of genome-wide techniques for investigating the neuronal transcriptome and epigenome promises great advances., Research at Barco’s lab is supported by the grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana., Peer reviewed